Figure 7.
Figure 7. CD4+ CD161+ drug-effluxing T cells maintain c-kit expression after stimulation. CD4+CD161+ T cells were sort-purified according to rhodamine effluxing capacity (Rholo and Rhohi) and were stained for c-kit expression after stimulation with anti-CD3/CD28 beads. (A) Representative FACS plots depict c-kit expression on CD4+CD161+Rholo T cells in response to stimulation. (B) Cumulative data from 5 independent experiments show the c-kit expression on CD4+CD161+Rholo, CD4+CD161+Rhohi, and CD4+CD161−. Statistics were calculated using Student t test. *P < .05; **P < .01; ***P < .001; ****P < .0001; ns = not significant. (C) CD4+CD161+ T cells were stained for ABCB1, followed by intracellular staining for Ki67. Representative dot plots show the expression of Ki67 on ABCB1+ vs ABCB1− CD161+CD4+ T cells. Cumulative data demonstrate the higher expression of Ki67 on ABCB1− noneffluxing CD161+CD4+ T cells. Mean ± SE of 3 separate experiments were shown.

CD4+CD161+drug-effluxing T cells maintain c-kit expression after stimulation. CD4+CD161+ T cells were sort-purified according to rhodamine effluxing capacity (Rholo and Rhohi) and were stained for c-kit expression after stimulation with anti-CD3/CD28 beads. (A) Representative FACS plots depict c-kit expression on CD4+CD161+Rholo T cells in response to stimulation. (B) Cumulative data from 5 independent experiments show the c-kit expression on CD4+CD161+Rholo, CD4+CD161+Rhohi, and CD4+CD161. Statistics were calculated using Student t test. *P < .05; **P < .01; ***P < .001; ****P < .0001; ns = not significant. (C) CD4+CD161+ T cells were stained for ABCB1, followed by intracellular staining for Ki67. Representative dot plots show the expression of Ki67 on ABCB1+ vs ABCB1 CD161+CD4+ T cells. Cumulative data demonstrate the higher expression of Ki67 on ABCB1 noneffluxing CD161+CD4+ T cells. Mean ± SE of 3 separate experiments were shown.

Close Modal

or Create an Account

Close Modal
Close Modal